Two bacteria that co-occur with C. difficile as emerging potential threats in planetary health

NewsGuard 100/100 Score

A new study published in the peer-reviewed OMICS: A Journal of Integrative Biology identified genes for virulence and antimicrobial resistance in two bacteria that co-occur with C. difficile, suggesting these pathogens as emerging potential threats in planetary health.

Thokur Sreepathy Murali, PhD, Ankit Singh Tanwar, Padival Shruptha and colleagues from Manipal Academy of Higher Education, India, and co-author Angela Brand, MD, PhD, MPH from Maastricht University, The Netherlands, performed comparative genome analyses of three Clostridia species, C. difficile, C. butyricum, and C. tertium.

C. difficile can cause diarrhea, colitis, sepsis and multiple organ dysfunction. C. butyricum and C. tertium, which reside in the gut, can harbor toxin/virulence genes, and thus, could pose a threat to human health.

Studies such as this one "will further improve our understanding of development of antimicrobial resistance, provide new avenues in genomic monitoring of emerging pathogens and offer better treatment strategies for crippling infectious diseases," state the investigators.

The study provides a timely application of comparative genomics in planetary health and opens up new avenues for diagnostics and therapeutics innovation. The findings unpack the potential threats and interactions of three Clostridia species. I welcome new manuscripts on multi-omics applications in planetary health for peer-review in the journal."

Vural Özdemir, MD, PhD, DABCP, Editor-in-Chief of OMICS

Source:
Journal reference:

Tanwar, A. S., et al. (2023) Emerging Pathogens in Planetary Health and Lessons from Comparative Genome Analyses of Three Clostridia Species. OMICS A Journal of Integrative Biology. doi.org/10.1089/omi.2023.0034.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nucleus Genomics ushers in a new era of personalized medicine to the public